Atlas Trials

Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease

Clinical trial NCT06458803 · COMPLETED

Trial details

NCT number
NCT06458803
Sponsor
Tongji Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Refractory ThrombocytopeniaConnective Tissue Diseases
Start date
2013-05-06
Primary completion
2023-05-11
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.